Repligen Corp. (RGEN)
115.15
+0.95
(+0.83%)
USD |
NASDAQ |
Mar 16, 16:00
115.15
0.00 (0.00%)
After-Hours: 20:00
Repligen Price : 115.15 for March 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Masimo Corp. | 175.39 |
| Orthofix Medical, Inc. | 11.88 |
| InfuSystem Holdings, Inc. | 9.57 |
| Tandem Diabetes Care, Inc. | 21.90 |
| Plus Therapeutics, Inc. | 0.2614 |
Price Related Metrics
| PE Ratio | 133.20 |
| PS Ratio | 8.823 |
| Price to Book Value | 3.080 |
| Price to Free Cash Flow | 71.04 |
| Earnings Yield | 0.75% |
| Market Cap | 6.487B |
| Operating PE Ratio | 127.96 |
| Normalized PE Ratio | 141.12 |